| Authors: |
Davis SM; Division of Global HIV/AIDS and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, GA., Habel MA; Division of Global HIV/AIDS and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, GA., Pretorius C; Modeling, Planning and Policy Analysis Center of Excellence, Avenir Health, Glastonbury, CT., Yu T; Modeling, Planning and Policy Analysis Center of Excellence, Avenir Health, Glastonbury, CT., Toledo C; Division of Global HIV/AIDS and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, GA., Farley T; Sigma3 Services SÀRL, Nyon, Switzerland., Kabuye G; Centers for Disease Control and Prevention, Kampala, Uganda; and., Samuelson J; Department of HIV, AIDS and Hepatitis; Key Populations and Innovative Prevention Team, World Health Organization, Geneva, Switzerland. |